Thaddeus Dryja

Scientific Advisor at Intergalactic Therapeutics

Thaddeus Dryja, M.D., is a Professor of Ophthalmology at Harvard Medical School and an eye pathologist at Massachusetts Eye and Ear. At the Novartis Institutes for Biomedical Research, he was the Head of Translational Medicine in Ophthalmology and then the Vice President and Head of Ophthalmology research. His research discoveries included finding compelling evidence for the recessive nature of oncogenic mutations at tumor suppressor genes like the retinoblastoma gene, the identification and cloning of the retinoblastoma gene, and the identification of 16 different genes responsible for retinitis pigmentosa and other forms of retinal degeneration and retinal dysfunction.